|
2025
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; recombinant p... |
|
2024
|
Invention
|
Genotyping cells using single-cell dna sequencing data.
Some aspects provide for techniques for ... |
|
|
Invention
|
Anti-cd45 antibody-drug conjugate pharmaceutical compositions. Disclosed are pharmaceutical compo... |
|
|
Invention
|
Compositions comprising genetically engineered hematopoietic stem cells and methods of use thereo... |
|
|
Invention
|
Egf-like module containing mucin-like hormone-like 2 (erm2) binding agents and methods of use the... |
|
|
Invention
|
Compositions and methods for inhibition of lineage specific proteins.
Disclosed herein are compo... |
|
|
Invention
|
Compositions and methods for the depletion of cells.
The invention provides compositions and met... |
|
|
Invention
|
Anti-cd45 antibodies and conjugates thereof. Disclosed are anti-CD45 antibodies, antigen binding ... |
|
|
Invention
|
Methods for treating hematopoietic malignancy. Aspects of the disclosure provide methods for trea... |
|
2023
|
Invention
|
Methods and compositions for gene modification and enrichment. Provided herein are compositions a... |
|
|
Invention
|
Anti-cd45-ign antibody drug conjugates and uses thereof. |
|
|
P/S
|
Cell therapy preparations, namely, stem cells and progenitor
cells for medical purposes; pharmac... |
|
|
Invention
|
Compositions and methods for artificial protospacer adjacent motif (pam) generation. inter alia i... |
|
|
Invention
|
Binding agents and methods of use thereof.
The present disclosure includes agents that specifica... |
|
|
Invention
|
Binding agents and methods of use thereof. The present disclosure includes agents that specifical... |
|
|
Invention
|
Compositions and methods for mediating epitope engineering.
Provided herein are compositions and... |
|
|
Invention
|
Compositions and methods for mediating epitope engineering. Provided herein are compositions and ... |
|
|
Invention
|
Compositions and methods for homology-directed repair gene modification.
Provided herein are met... |
|
|
Invention
|
Compositions and methods for homology-directed repair gene modification. Provided herein are meth... |
|
|
P/S
|
cell therapy preparations, namely, stem cells and progenitor cells for medical purposes; pharmace... |
|
|
Invention
|
Fc silenced antibody drug conjugates (adcs) and uses thereof.
Disclosed are antibodies and antib... |
|
2022
|
Invention
|
Compositions and methods for erm2 modification. Provided herein are gRNA comprising a targeting d... |
|
|
Invention
|
Fusion polypeptides for genetic editing and methods of use thereof.
Provided herein are fusion p... |
|
|
Invention
|
Fusion polypeptides for genetic editing and methods of use thereof. Provided herein are fusion po... |
|
|
Invention
|
Compositions and methods for multiplex base editing in hematopoietic cells.
When a cancer patien... |
|
|
Invention
|
Compositions and methods for multiplex base editing in hematopoietic cells. When a cancer patient... |
|
|
Invention
|
Compositions and methods for allogeneic transplantation.
Described herein are compositions and m... |
|
|
Invention
|
Compositions and methods for gene modification.
Provided herein are methods of making geneticall... |
|
|
Invention
|
Compositions and methods for gene modification. Provided herein are methods of making genetically... |
|
|
Invention
|
Chimeric antigen receptors for treatment of cancer.
Provided herein are chimeric antigen recepto... |
|
|
Invention
|
Nfat-responsive reporter systems for assessing chimeric antigen receptor activation and methods o... |
|
|
Invention
|
Chimeric antigen receptors for treatment of cancer. e.g.e.g., leukemias such as acute myeloid leu... |
|
|
Invention
|
Inhibitor oligonucleotides and methods of use thereof.
Provided herein are oligonucleotides comp... |
|
|
Invention
|
Inhibitor oligonucleotides for crispr/cas gene editing and methods of use thereof. Provided herei... |
|
|
Invention
|
Genetically engineered hematopoietic stem cells and uses thereof.
Genetically engineered hematop... |
|
|
Invention
|
Photocleavable guide rnas and methods of use thereof.
Provided herein are photocleavable guide R... |
|
|
Invention
|
Photocleavable guide rnas and methods of use thereof. Provided herein are photocleavable guide RN... |
|
2021
|
Invention
|
Compositions and methods for cd34 gene modification.
Provided herein are gRNA comprising a targe... |
|
|
P/S
|
Cell therapy preparations, namely, stem cells and progenitor cells for medical purposes; pharmace... |
|
|
Invention
|
Methods and compositions relating to genetically engineered cells expressing chimeric antigen rec... |
|
|
Invention
|
Compositions and methods for bcma modification.
Provided herein are gRNA comprising a targeting ... |
|
|
Invention
|
Compositions and methods for treating hematopoietic malignancy.
Aspects of the disclosure provid... |
|
|
Invention
|
Compositions and methods for cd30 gene modification.
Provided herein are gRNA comprising a targe... |
|
|
Invention
|
Chimeric antigen receptor expression systems.
Aspects of this disclosure provide nucleic acid co... |
|
|
Invention
|
Compositions and methods for cd6 modification.
Provided herein are gRNA comprising a targeting d... |
|
|
Invention
|
Compositions and methods for cd7 modification.
Provided herein are gRNA comprising a targeting d... |
|
|
Invention
|
Compositions and methods for cd5 modification.
Provided herein are gRNA comprising a targeting d... |
|
|
Invention
|
Compositions and methods for cd38 modification.
Provided herein are gRNA comprising a targeting ... |
|
|
Invention
|
Chimeric antigen receptors for treatment of cancer.
Provided are chimeric antigen receptors (CAR... |
|
|
Invention
|
Single domain antibodies against cd33.
The present disclosure includes antibodies that specifica... |
|
|
Invention
|
Compositions and methods for cd123 modification.
This disclosure provides, e.g., novel cells hav... |
|
|
Invention
|
Compositions and methods for cll1 modification.
This disclosure provides, e.g., novel cells havi... |
